Day One Biopharmaceuticals Inc Working Capital to Net Assets Ratio
Day One Biopharmaceuticals Inc working capital to net assets ratio. Day One Biopharmaceuticals Inc (DAWN) has a Working Capital to Net Assets ratio of 96.1% as of September 2025. Working capital of $433.50 Million (current assets of $489.97 Million minus current liabilities of $56.47 Million) is measured against net assets of $450.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Day One Biopharmaceuticals Inc (2019–2024)
Working capital to net assets ratio of Day One Biopharmaceuticals Inc from 2019 to 2024. This chart shows how Day One Biopharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 96.1%, reflecting working capital of $433.50 Million against net assets of $450.87 Million USD. See DAWN days of operational coverage to measure how many days the company can operate on defensive assets alone.
Day One Biopharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2019–2024)
Day One Biopharmaceuticals Inc working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Day One Biopharmaceuticals Inc from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Day One Biopharmaceuticals Inc total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 97.2% | $488.88 Million | $502.75 Million | $562.33 Million | $73.45 Million | ▼ -2.5 pp |
| 2023 | 99.8% | $345.77 Million | $346.54 Million | $375.27 Million | $29.51 Million | ▲ +0.0 pp |
| 2022 | 99.8% | $331.26 Million | $332.04 Million | $347.87 Million | $16.61 Million | ▼ -0.1 pp |
| 2021 | 99.8% | $280.71 Million | $281.15 Million | $289.37 Million | $8.66 Million | ▲ +0.7 pp |
| 2020 | 99.1% | $43.08 Million | $43.46 Million | $45.07 Million | $2.00 Million | ▲ +587.3 pp |
| 2019 | -488.2% | $25.32 Million | $-5.19 Million | $27.34 Million | $2.02 Million | — |